Age Not Predictive of Recurrence in HER2 Breast Cancer

A retrospective analysis of the HERA trial indicated that young age was not associated with early recurrence in women with HER2-positive breast cancer, despite previous research suggesting that young age at diagnosis might be a risk factor for recurrence and death.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news